Know how

Protein production for research & POC studies

GTP helps you produce the recombinant protein material needed for your research and POC studies and obtain the process information required for a seamless transition to manufacturing.

We have acquired vast experience over 1200 recombinant protein production projects

GTP is the ideal partner for your early stage recombinant protein projects

Recombinant protein development projects generally start with research scale production for Proof-of-Concept or measure of developability.

These feasibility studies are important contributors to the success of a global protein programme. They should be contemplated with agility and with a mind open to innovation, whilst understanding the risks associated with each option.

The majority of CMOs with a main mission to manufacture protein for clinical trials and market supply are neither willing nor structured appropriately to be competitive with this type of studies.

Most academic protein platforms or CROs are able to produce milligram scale quantities of recombinant proteins, but might lack the global programme perspective, consequently calling for a redesign as the projects moves forward.

With a vivid scientific interest in all - even “non-conventional” - protein projects, we have, in the last 15 years, acquired vast  experience over 1200 different  recombinant protein projects. A large number of those were a Proof-of-Concept part of a larger development programme in which we were also involved.

With our combined experience of a diversity of proteins and expression systems, we are able to design solutions for even the most challenging proteins 

We add value to your early stage recombinant protein project by offering a unique mix of protein research proficiency and process expertise. Through our experience in development, scale-up, validation and transfer we will help you understand the challenges ahead from the get-go.

Our organization and capabilities are structured to handle these small scale recombinant protein productions for research and POC studies: we offer the adequate flexibility, turnaround-time and pricing structure.

For non-Mab proteins, when there is no evidence pointing towards a specific expression system, we can perform comparative feasibility studies thanks to our multi-system capabilities.
Our combined experience of hundreds of challenging recombinant proteins and of process development is a great asset to advise on the most suitable and least risky strategy for your programme.

Research & process Process development for complex proteins 1